A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)

Research Site, Brussels

Research Site, Rosario

Research Site, København Ø

Research Site, Edegem

Research Site, Seoul

Research Site, Innsbruck

Research Site, Bethesda

Research Site, Durham

Research Site, Atlanta

Research Site, Hanover

Research Site, Toulouse

Research Site, Pessac

Research Site, Haifa

Research Site, Santander

Research Site, Bologna

Research Site, Columbus

Research Site, Cleveland

Research Site, Kfar Saba

Research Site, Ann Arbor

Research Site, Petah Tikva

Research Site, Holon

Research Site, Lille

Research Site, Tel Aviv

Research Site, Strasbourg

Research Site, Mannheim

Research Site, Kirchheim

Research Site, Rehovot

Research Site, Salt Lake City

Research Site, Jerusalem

Research Site, La Jolla

Research Site, Suresnes

Research Site, Delhi

Research Site, Tianjin

Research Site, Ajmer

Research Site, Xiamen

Research Site, Ahmedabad

Research Site, Zhengzhou

Research Site, Chengdu

Research Site, Ramat Gan

Research Site, Chiba

Research Site, Hamamatsu

Research Site, Ichikawa-shi

Research Site, Kawasaki-shi

Research Site, Nishinomiya-shi

Research Site, Osaka

Research Site, Sendai

Research Site, Rotterdam

Research Site, Chęciny

Research Site, Gdansk

Research Site, Lodz

Research Site, London